MKI67 and neoplasm: Ki-67 staining index, or the ratio of immunoreactive cell nuclei, has been utilized to direct treatment decisions in cases of hormone susceptible breast cancer, in addition to its usage in diagnostic and prognosis investigations of different neoplasms [6].